We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$4.42B
AUM Growth
+$200M
(+4.7%)
Cap. Flow
+$138M
Cap. Flow
% of AUM
3.13%
Top 10 Holdings %
Top 10 Hldgs %
20.05%
Holding
1,701
New
123
Increased
762
Reduced
644
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
|
+$34.6M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$24.7M |
| 3 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$22.5M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$15.7M |
| 5 |
SPDR Gold Trust
GLD
|
+$14.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$20.4M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$15.2M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$10.9M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$10.6M |
| 5 |
State Street DoubleLine Total Return Tactical ETF
TOTL
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.64% |
| 2 | Technology | 4.52% |
| 3 | Healthcare | 4.42% |
| 4 | Consumer Staples | 4.24% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Elevance Health
ELV
$84.7B
| $1.7M | 0.04% |
12,192
+1,001
| +9% | +$134K |
|
402
Vanguard Financials ETF
VFH
$13.8B
| $1.69M | 0.04% |
36,418
-24,574
| -40% | -$1.09M |
|
403
Applied Materials
AMAT
$417B
| $1.68M | 0.04% |
79,507
+18,746
| +31% | +$342K |
|
404
FedEx
FDX
$76.3B
| $1.66M | 0.04% |
10,228
-55
| -0.5% | -$7.65K |
|
405
Adams Diversified Equity Fund
ADX
$3.28B
| $1.66M | 0.04% |
131,143
+94,698
| +260% | +$1.14M |
|
406
Seagate
STX
$186B
| $1.64M | 0.04% |
47,733
+3,871
| +9% | +$125K |
|
407
iShares California Muni Bond ETF
CMF
$4.62B
| $1.64M | 0.04% |
27,492
+2,096
| +8% | +$125K |
|
408
Invesco Pharmaceuticals ETF
PJP
$498M
| $1.62M | 0.04% |
27,038
-14,966
| -36% | -$916K |
|
409
Lumen
LUMN
$6.58B
| $1.62M | 0.04% |
50,548
+6,865
| +16% | +$192K |
|
410
Halliburton
HAL
$28.2B
| $1.61M | 0.04% |
45,191
+3,623
| +9% | +$118K |
|
411
First Trust Consumer Staples AlphaDEX Fund
FXG
$229M
| $1.61M | 0.04% |
34,843
-15,651
| -31% | -$690K |
|
412
Becton Dickinson
BDX
$49.4B
| $1.6M | 0.04% |
10,823
-57
| -0.5% | -$8.09K |
|
413
First Financial Corp
THFF
$967M
| $1.6M | 0.04% |
46,838
+715
| +2% | +$23.6K |
|
|
FISV
414
Fiserv Inc
FISV
$28B
| $1.6M | 0.04% |
31,164
+11,418
| +58% | +$541K |
|
415
NNN REIT
NNN
$8.71B
| $1.59M | 0.04% |
34,524
+1,546
| +5% | +$67.2K |
|
|
EMC
416
DELISTED
EMC CORPORATION
EMC
| $1.59M | 0.04% |
59,784
-313
| -0.5% | -$7.93K |
|
417
Fidelity MSCI Communication Services Index ETF
FCOM
$1.78B
| $1.58M | 0.04% |
+52,988
| New | +$1.46M |
|
|
EVV
418
Eaton Vance Limited Duration Income Fund
EVV
$1.07B
| $1.58M | 0.04% |
119,728
+82,781
| +224% | +$1.03M |
|
419
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.47B
| $1.56M | 0.04% |
31,992
+3,646
| +13% | +$178K |
|
420
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$524M
| $1.56M | 0.04% |
29,785
-1,189
| -4% | -$61.4K |
|
421
Ambarella
AMBA
$3.64B
| $1.53M | 0.03% |
34,300
+2,594
| +8% | +$107K |
|
422
iShares US Healthcare ETF
IYH
$3.76B
| $1.51M | 0.03% |
53,700
-10,315
| -16% | -$286K |
|
423
Invesco Leisure and Entertainment ETF
PEJ
$307M
| $1.51M | 0.03% |
40,744
-3,785
| -9% | -$130K |
|
424
First Merchants
FRME
$2.69B
| $1.5M | 0.03% |
+63,546
| New | +$1.45M |
|
|
WFM
425
DELISTED
Whole Foods Market Inc
WFM
| $1.5M | 0.03% |
48,113
-3,715
| -7% | -$116K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Cambridge Investment Research Advisors held 1,701 positions worth $4.42B, up 4.7% from $4.22B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors deployed $138M of net new capital in Q1 2016, opening 123 new positions and adding to 762 existing holdings. Its largest new stake was Vanguard Long-Term Treasury ETF: 35,170 shares worth $2.83M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, down from 4.9% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $20.4M trimmed.
- Cambridge Investment Research Advisors's largest Q1 2016 buy was Vanguard Long-Term Treasury ETF: 35,170 shares worth $2.83M.
- Cambridge Investment Research Advisors added most to DIPLOMAT PHARMACY, INC. in Q1 2016, an estimated $34.6M increase.
- Cambridge Investment Research Advisors's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $20.4M.
- Cambridge Investment Research Advisors fully exited iShares Currency Hedged MSCI Emerging Markets in Q1 2016, selling an estimated $1.72M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $4.42B portfolio in Q1 2016.
- Cambridge Investment Research Advisors opened 123 new positions and closed 96 in Q1 2016.
- Cambridge Investment Research Advisors's portfolio value rose 4.7% quarter-over-quarter to $4.42B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2016, filed 3 May 2016.